In last trading session, PAVmed Inc (NASDAQ:PAVM) saw 0.31 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $0.66 trading at $0.05 or 8.27% at ring of the bell on the day assigns it a market valuation of $7.31M. That closing price of PAVM’s stock is at a discount of -330.3% from its 52-week high price of $2.84 and is indicating a premium of 13.64% from its 52-week low price of $0.57. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.12 million shares which gives us an average trading volume of 221.90K if we extend that period to 3-months.
PAVmed Inc (NASDAQ:PAVM) trade information
Upright in the green during last session for gaining 8.27%, in the last five days PAVM remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $0.66 price level, adding 2.22% to its value on the day. PAVmed Inc’s shares saw a change of 5.18% in year-to-date performance and have moved -3.59% in past 5-day. PAVmed Inc (NASDAQ:PAVM) showed a performance of -1.49% in past 30-days. Number of shares sold short was 0.32 million shares which calculate 1.43 days to cover the short interests.
PAVmed Inc (PAVM) estimates and forecasts
This year revenue growth is estimated to rise 22.86% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 580k for the same. And 2 analysts are in estimates of company making revenue of 21k in the next quarter. Company posted 1.05M and 1.01M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.21% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 127.29% while estimates for its earnings growth in next 5 years are of 59.25%.
PAVmed Inc (NASDAQ:PAVM)’s Major holders
Insiders are in possession of 28.70% of company’s total shares while institution are holding 7.84 percent of that, with stock having share float percentage of 10.99%. Investors also watch the number of corporate investors in a company very closely, which is 7.84% institutions for PAVmed Inc that are currently holding shares of the company.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 79.69 shares of worth $52594.0 or 0.72% of the total outstanding shares. The later fund manager was in possession of 51.58 shares on Dec 31, 2024 , making its stake of worth around $34044.0 in the company or a holder of 0.47% of company’s stock.
